CGM Plus Nutrition Counseling Can Improve Glycemic Control in T2D
A 12-month quality improvement project provides insight into the effects of using CGM and supplemental dietary counseling on glycemic control in adult T2D patients with suboptimal glycemic control.
Switching from Daily Injections to Advanced Hybrid Closed Loop System Can Improve Glycemic Control
A single-arm, open-label study provides insight into the effects of switching from multiple daily insulin injections to use of an advanced hybrid closed loop system on glycemic control in pediatric patients with type 1 diabetes.
Study Compares Continuous Insulin Infusions vs. Multiple Daily Injections for Glycemic Control in T1D
A systematic review and meta-analysis details the apparent lack of significant difference for glycemic control observed with subcutaneous insulin infusions versus multiple daily injections in patients with type 1 diabetes using real-time continuous glucose monitoring.
PROMISE Study Provides Insight into Safety, Accuracy of Eversense 180-Day CGM System
Data from the PROMISE study provide clinicians with comprehensive insight into the safety and accuracy of the 180-day CGM system from Eversense in patients with diabetes.
Comparing Implantable and Transcutaneous CGM in Patients with Type 1 Diabetes
A monocentric randomized crossover study of 16 subjects provides insight into the difference in glycemic control, device acceptance, and psychological outcomes based on use of implantable versus transcutaneous.
Study Finds CGM Use Could Improve Emotional Well-Being in Type 1 Diabetes
Results of a systematic review and meta-analysis detail the reduction in fear of hypoglycemia and general improvement in satisfaction associated with use of continuous glucose monitoring in patients with type 1 diabetes.
Using CGM-Derived TIR to Predict Microvascular Complications in Type 2 Diabetes
A meta-analysis including 11 studies with nearly 14k patients is providing insight into associations between time in range and risk of microvascular complications in patients with type 2 diabetes.
Patients with Poorly Controlled Diabetes Could Benefit from CGM
Data from the MOBILE study detail the potential impact of continuous glucose monitoring on HbA1c level compared with blood glucose meter monitoring in a population of patients with type 2 diabetes treated with basal insulin without prandial insulin.
CGM Use Could Improve Glucose Control in Diabetes of the Exocrine Pancreas
A cross-sectional study of 83 patients with diabetes of the exocrine pancreas provides insight into the potential benefits of continuous glucose monitoring among these patients.
Impact of Lockdown Measures on Glucose Control in Type 1 Diabetes
A meta-analysis of observational studies provides clinicians with a comprehensive overview of the impact of lockdown measures during the COVID-19 pandemic on glucose control in patients with type 1 diabetes.
The technology specific portion of the American Diabetes Association Standards of Medical Care in Diabetes—2022.
Practice resources related to CGM and glucose monitoring compiled by the Association of Diabetes Care & Education Specialists, including a personal playbook for implementing CGM into your practice.
Resources from the Endocrine Society’s most recent guideline recommendations on diabetes technology, including a video, educational slide deck, and a guidelines pocket card.
American Association of Clinical Endocrinology webpage hosting resources, including links to guidelines and a podcast, outlining guidance for diabetes management incorporating advanced diabetes technology.
A basic overview of continuous glucose monitoring for patients prepared by the National Institute of Diabetes and Digestive and Kidney Disease. This resource contains information outlining use of CGM as well as benefits and limits of the technology.
Patient-specific resources providing a comprehensive look at continuous glucose monitoring, including a section with questions to consider with your healthcare provider and an expert-led video explaining continuous glucose monitoring.
